Friday, April 30, 2010
Illumina Names Two VPs
San Diego-based Illumina, a developer of gene sequencing tools, said today that it has named Elizabeth Brady as the firm's Vice President, Global Supply Chain, and Emily S. Winn-Deen, Ph.D., as its Vice President, Diagnostics Development. Brady joins from Boston Scientific Corporation, and has also served at Tellabs Operations and 3Com. Winn-Deen joins from Rx Dx Advisors, and also has served at Cepheid, Roche Molecular Systems, Applera Corporation, Oncor, and Bayer Diagnostics.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More